Digital Pathology Market Size to Reach USD 2,234.9 Million at 13.2% CAGR by 2030 | Reports and Data

Increasing adoption of digital pathology to enhance lab efficiency is driving market revenue growth.

According to a recent report by Reports and Data, the global Digital Pathology Market is expected to reach USD 2,234.9 Million by 2030, growing at a CAGR of 13.2% during the forecast period. The increase in the prevalence of chronic and cardiovascular diseases is the primary driving factor behind the development of new diagnostic solutions.

As the frequency of these diseases rises, there is a need for Digital Pathology systems that can provide accurate diagnoses. Furthermore, the growing application of Digital Pathology in drug development and companion diagnostics is driving Digital Pathology market revenue growth.

Get a free sample PDF of the report, visit @

The field of Digital Pathology encompasses the digitization and handling of pathology data and images, including slides, within a digital framework. By utilizing scanning instruments, high-quality digital images can be generated from glass slides, which can then be accessed and analyzed on various devices, such as computers and mobile phones. The global Digital Pathology market is experiencing an upsurge in revenue growth due to the growing need for precise diagnoses and the increasing investment in cutting-edge Digital Pathology systems.

Key players in the Digital Pathology Market:

  • Leica Biosystems Nussloch GmbH
  • Hamamatsu Photonics K.K
  • Hoffmann-La Roche Ltd
  • Apollo Enterprise Imaging Corp
  • XIFIN, Inc.
  • Huron Technologies International Inc
  • Visiopharm A/S
  • Aiforia Technologies
  • Akoya Biosciences, Inc

There is a significant shortage of pathologists worldwide, especially in Africa and the Asia Pacific, which has resulted in a supply-demand imbalance. Pathologists perform vital laboratory tests necessary for diagnosing illnesses. In such circumstances, Digital Pathology can play an important role in facilitating the secure and timely exchange of essential information between medical professionals and pathologists across geographical borders.

Moreover, the emergence of advanced technologies such as Artificial Intelligence (AI) and Machine Learning (ML) is helping pathologists to quickly and accurately identify diseases, thereby enhancing their effectiveness. Due to the critical shortage of pathologists, it is expected that Digital Pathology will be increasingly utilized for remote pathological consulting and services in regions such as Africa and APAC.

To know more about the latest insights of the report, visit@

The report also highlights some key highlights, such as the collaboration between Visiopharm and Agilent Technologies, Inc. to co-market Visiopharm’s portfolio of AI-driven Precision Pathology software and Agilent’s automated pathology staining solutions portfolio. The alliance aims to address the unmet requirements of pathology laboratories worldwide and develop technology, products, and services that improve pathology lab uniformity and speed up correct diagnosis.

The report segments the Digital Pathology market based on product, type, application, end-use, and region. The scanner segment accounted for the largest revenue share in 2021, driven by cloud-enabled Digital Pathology scanners that offer the most flexibility for storing, archiving, and managing digital pictures and metadata. The Digital Pathology segment accounted for the largest revenue share in 2021, driven by the more accurate analysis and faster access to previously linked instances. The drug discovery segment accounted for the largest revenue share in 2021, driven by Digital Pathology’s ability to enhance therapy possibilities for a number of disorders. The hospital segment accounted for the largest revenue share in 2021 due to the huge number of medical procedures and operations performed in hospitals.

North America accounted for the largest revenue share in 2021, driven by the development and innovation in Digital Pathology products, the presence of several biotechnologies and medical product industries, as well as advanced healthcare facilities.

In conclusion, the global Digital Pathology market is expected to grow significantly over the forecast period, driven by the rise in the prevalence of chronic and cardiovascular diseases, the need for accurate diagnoses, and the increasing application of Digital Pathology in drug development and companion diagnostics. The use of emerging technologies such as Artificial Intelligence (AI) and Machine Learning (ML) can assist pathologists in identifying diseases more quickly and improving their effectiveness.

Request customization of the report @

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.

Browse for more reports…

Macular Degeneration Market –

Graphene Oxide Market –

Lymphoma Market –

Advanced Pancreatic Cancer Market –

Musculoskeletal Pain Treatment Market –

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.


John W, Head of Business Development
Reports And Data | Web:
Direct Line: +1-212-710-1370
LinkedIn | Twitter | Blogs

Related Articles

Back to top button